Health Discovery Corporation
06/12/2026 | Press release | Distributed by Public on 06/12/2026 11:38
Termination Notice (Form 15-15D)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 333-62216
Health Discovery Corporation
(Exact name of registrant as specified in its charter)
Post Office Box 616, Devault, PA 19432 1-847-721-1200
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
Common Stock, no par value
(Title of each class of securities covered by this Form)
n/a
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ☐ |
| Rule 12g-4(a)(2) | ☐ |
| Rule 12h-3(b)(1)(i) | ☐ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 12h-3(b)(1)(ii) | ☐ |
| Rule 15d-6 | ☒ |
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: 276
Pursuant to the requirements of the Securities Exchange Act of 1934, Health Discovery Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: June 11, 2026 | By: | /s/ Alan Hauser | ||
| Name: | Alan Hauser | |||
| Title: | Chief Executive Officer | |||
Health Discovery Corporation published this content on June 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on June 12, 2026 at 17:39 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]